Navigation Links
CVS Caremark Issues Statement on Settlement Concerning Disposal of Patient Information at its Retail Stores
Date:2/18/2009

WOONSOCKET, R.I., Feb. 18 /PRNewswire-FirstCall/ -- CVS Caremark Corporation (NYSE: CVS) announced today that it has entered into an agreement with the U.S. Federal Trade Commission (FTC) and the U.S. Department of Health and Human Services Office for Civil Rights (OCR) concerning disposal of patient information at its retail pharmacy stores. The agreement resolves an investigation prompted by media reports from 2006 about alleged incidents of inadvertent disposal of patient information in dumpsters at a limited number of CVS/pharmacy locations in a manner that was inconsistent with the Company's waste disposal procedures.

The investigation was initiated prior to the merger between CVS and Caremark, involved CVS/pharmacy retail locations only and did not relate to the PBM business. The Company responded to these reports by promptly enhancing its retail waste disposal policies and training programs, and instituted a chain-wide shredding program for confidential waste to further guard against inadvertent disposal of confidential information in the regular trash.

CVS Caremark is not aware of any consumer harm arising out of, or related to, the alleged incidents. Per the agreement with the FTC and the OCR, the Company has expressly denied engaging in any wrongful conduct and agreed to settle the matter in order to avoid the time and expense of further legal proceedings.

CVS Caremark is committed to being an industry leader in privacy matters and places high priority on protecting the privacy of its customers and plan participants. The Company has comprehensive policies and procedures in place to safeguard personal and health information and follows federal and state laws in handling this sensitive data. CVS Caremark's settlement obligations with the FTC and the OCR reinforce existing business practices in regard to protecting patient information, employee training on privacy issues, and monitoring the effectiveness of privacy policies and procedures on a regular basis.

About CVS Caremark

CVS Caremark (NYSE: CVS) is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 6,800 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investor Relations section of the Company's Web site, at http://cvscaremark.com/investors, as well as through the Newsroom section of the Company's Web site, at http://cvscaremark.com/newsroom.

CONTACTS

Media: Eileen Howard Dunn, 401-770-4561

Investors: Nancy Christal, 401-770-3614


'/>"/>
SOURCE CVS Caremark Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caremark Customer Care Centers Recognized for Customer Satisfaction Excellence by J.D. Power and Associates Certified Call Center Program(SM)
2. CVS Caremark Presents Influenza Vaccine Data at Rescheduled 2008 DMAA Annual Meeting
3. CVS Caremark Named Finalist in URAC Annual Best Practices in Health Care Consumer Empowerment and Protection Awards
4. CVS Caremark Applauds FTCs Leadership on Follow-on Biologics
5. CVS Caremark All Kids Can Announces the Opening of a Boundless Playground in Los Angeles to Serve Children of All Abilities
6. CVS Caremark Names Troyen Brennan, MD, EVP, Chief Medical Officer
7. SilverScript Insurance Company, a CVS Caremark Company, Provides Variety of Medicare Prescription Drug Plan Options for 2009
8. CVS Caremark Partners with Google Health to Provide Consumers with Online Access to their Prescription History through Caremark.com
9. CVS Caremark Reports Record Second Quarter Revenues, Operating Profit, and Earnings
10. CVS Caremark Employees Raise $1 Million and Increase Awareness for Children with Disabilities through Easter Seals Walk With Me Events Nationwide
11. CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual meeting of ... (WMIC), will be held in New York City, NY on September 7 – ... congress will highlight and emphasize how imaging reveals a greater understanding of the ...
(Date:2/10/2016)... ... February 10, 2016 , ... Early this week, Team Iconic at ... of Nestlé KITKAT as the first global confectionery brand sourced from 100% sustainable cocoa. ... the quality of their product, through activities that focus on better farming, better lives ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... a full-service health care communications company offering education, research and medical media, ... practitioners and specialists working in infectious diseases. , As the all-inclusive resource ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO Jay ... 2.0 version at the International Roofing Expo in Orlando, Florida on February 17-19. ... most advanced weather technology in the hands of consumers, roofing contractors, manufacturers and ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... (VRI) within Healthcare, recently partnered with Heart City Health Center to ... nearly 23 years, Heart City Health Center has provided the Elkhart community with ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 10, 2016 --> --> This press ... .  --> Japan .  --> A separate press ... With submission, Shire continues to strengthen its presence ... Shire continues to strengthen its presence ... Shire continues to strengthen its presence in ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 /PRNewswire/ ... in viral gene therapy manufacturing, and Renova™ Therapeutics, a ... failure and other chronic diseases, have entered into a ... and produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use ... --> --> This relationship will leverage ...
(Date:2/10/2016)... Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko ... completed, through its indirect wholly-owned subsidiary Laurel Acquisition Inc. ... outstanding shares of common stock of Ocata Therapeutics, Inc. ... "Ocata") for a price of US$8.50 per share net ... the Tender Offer on November 19, 2015, U.S. Eastern ...
Breaking Medicine Technology: